Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610 · see citing works

The neurobiology of antiepileptic drugs

Rogawski, M. A., & Löscher, W. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1430 · Cited by 1,243 · see citing works

Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites

Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752 · see citing works

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

Barton, M. E., Klein, B. D., Wolf, H. H., & White, H. S. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00302-3 · Cited by 614 · see citing works

An update on GABAA receptors

Mehta, A. K., & Ticku, M. K. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00052-6 · Cited by 611 · see citing works

The role of cytokines in the pathophysiology of epilepsy

Vezzani, A., Balosso, S., & Ravizza, T. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.03.009 · Cited by 558 · see citing works

Key factors in the discovery and development of new antiepileptic drugs

Bialer, M., & White, H. S. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542 · see citing works

The Treatment of Epilepsy

(2004) · Wiley eBooks · doi:10.1002/9780470752463 · Cited by 509 · see citing works

Adjunctive perampanel for refractory partial-onset seizures

French, J. A., Krauss, G. L., Biton, V., Squillacote, D., Yang, H., Laurenza, A., Kumar, D., Rogawski, M. A., Campanille, V., Floridia, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182635735 · Cited by 478 · see citing works

Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)

Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477 · see citing works

2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP–dependent metabolic regulation of chromatin structure

Garriga-Canut, M., Schoenike, B. A., Qazi, R., Bergendahl, K., Daley, T. J., Pfender, R. M., Morrison, J. F., Ockuly, J. C., Stafstrom, C. E., Sutula, T. P., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1791 · Cited by 446 · see citing works

Randomized phase III study 306

Krauss, G. L., Serratosa, J. M., Villanueva, V., Endzinienė, M., Hong, Z., French, J. A., Yang, H., Squillacote, D., Edwards, H. B., Zhu, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318254473a · Cited by 430 · see citing works

Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305

French, J. A., Krauss, G. L., Steinhoff, B. J., Squillacote, D., Yang, H., Kumar, D., & Laurenza, A. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03638.x · Cited by 423 · see citing works

Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy

Hanada, T., Hashizume, Y., Tokuhara, N., Takenaka, O., Kohmura, N., Ogasawara, A., Hatakeyama, S., Ohgoh, M., Ueno, M., & Nishizawa, Y. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03109.x · Cited by 411 · see citing works

Development of new antiepileptic drugs: challenges, incentives, and recent advances

Perucca, E., French, J. A., & Bialer, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70215-6 · Cited by 338 · see citing works

(S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2 R,3 S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1β and IL-18

Wannamaker, W., Davies, R. M. D., Namchuk, M., Pollard, J., Ford, P. J., Ku, G., Decker, C. J., Charifson, P. S., Weber, P., Germann, U. A., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111344 · Cited by 326 · see citing works

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies

Stein, M., Lin, H., Jeyamohan, C., Dvorzhinski, D., Gounder, M., Bray, K., Eddy, S., Goodin, S., White, E., & DiPaola, R. S. (2010) · The Prostate · doi:10.1002/pros.21172 · Cited by 291 · see citing works

Electrical Stimulation of the Anterior Nucleus of the Thalamus for Intractable Epilepsy: A Long‐term Follow‐up Study

Lim, S., Lee, S., Tsai, Y., Chen, I.-A., Tu, P., Chen, J., Chang, H., Su, Y., & Wu, T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00898.x · Cited by 283 · see citing works

Optimizing Cancer Radiotherapy with 2-Deoxy-D-Glucose

Singh, D., Banerji, A. K., Dwarakanath, B. S. R., Tripathi, R. P., Gupta, J. P., Mathew, T. L., Ravindranath, T., & Jain, V. K. (2005) · Strahlentherapie und Onkologie · doi:10.1007/s00066-005-1320-z · Cited by 265 · see citing works

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties

Gillard, M. R., Fuks, B., Leclercq, K., & Matagne, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.064 · Cited by 252 · see citing works

Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity

Kenda, B., Matagne, A., Talaga, P. E., Pasau, P., Differding, E., Lallemand, B., Frycia, A., Moureau, F., Klitgaard, H., Gillard, M. R., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030913e · Cited by 225 · see citing works

Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.09.005 · Cited by 225 · see citing works

Modulation of Hippocampal Excitability and Seizures by Galanin

Mazarati, A. M., Hohmann, J. G., Bacon, A., Liu, H., Sankar, R., Steiner, R. A., Wynick, D., & Wasterlain, C. G. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06276.2000 · Cited by 224 · see citing works

Anti‐convulsive and anti‐epileptic properties of brivaracetam (ucb 34714), a high‐affinity ligand for the synaptic vesicle protein, SV2A

Matagne, A., Margineanu, D., Kenda, B., Michel, P., & Klitgaard, H. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.198 · Cited by 223 · see citing works

Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors

Herd, M. B., Belelli, D., & Lambert, J. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.007 · Cited by 206 · see citing works

Galanin Modulation of Seizures and Seizure Modulation of Hippocampal Galanin in Animal Models of Status Epilepticus

Mazarati, A. M., Liu, H., Soomets, U., Sankar, R., Shin, D. H., Katsumori, H., Langel, Ü., & Wasterlain, C. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10070.1998 · Cited by 180 · see citing works

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

Trenité, D. G. A. K.-N., Marescaux, C., Stodieck, S. R. G., Edelbroek, P. M., & Oosting, J. (1996) · Epilepsy Research · doi:10.1016/s0920-1211(96)00031-9 · Cited by 180 · see citing works

Guidelines for EEG in encephalopathy related to ESES/CSWS in children

Boer, M. S. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02211.x · Cited by 179 · see citing works

Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.09.001 · Cited by 179 · see citing works

Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1β production

Ravizza, T., Noè, F. M., Zardoni, D., Vaghi, V., Sifringer, M., & Vezzani, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.007 · Cited by 178 · see citing works

Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)

Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00108-9 · Cited by 178 · see citing works

A Pharmacology Primer: Theory, Applications, and Methods

Kenakin, T. (2006) · Cited by 174 · see citing works

SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

Kaminski, R. M., Matagne, A., Leclercq, K., Gillard, M. R., Michel, P., Kenda, B., Talaga, P. E., & Klitgaard, H. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.11.021 · Cited by 168 · see citing works

Anticonvulsant and antiepileptic actions of 2‐deoxy‐D‐glucose in epilepsy models

Stafstrom, C. E., Ockuly, J. C., Murphree, L. J., Valley, M. T., Roopra, A., & Sutula, T. P. (2009) · Annals of Neurology · doi:10.1002/ana.21603 · Cited by 165 · see citing works

Galanin reduces release of endogeneous excitatory amino acids in the rat hippocampus

Zini, S., Roisin, M. P., Langel, Ü., Bartfai, T., & Ben-Ari, Y. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90162-3 · Cited by 160 · see citing works

Adjunctive brivaracetam for refractory partial-onset seizures

French, J. A., Costantini, C., Brodsky, A. L., & von Rosenstiel, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ec7f7f · Cited by 157 · see citing works

Chronic Treatment with the Neuroactive Steroid Ganaxolone in the Rat Induces Anticonvulsant Tolerance to Diazepam but Not to Itself

Reddy, D. S., & Rogawski, M. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39026-3 · Cited by 151 · see citing works

Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)

Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(00)00171-6 · Cited by 151 · see citing works

The Second Galanin Receptor GalR2 Plays a Key Role in Neurite Outgrowth from Adult Sensory Neurons

Mahoney, S.-A., Hosking, R., Farrant, S., Holmes, F. E., Jacoby, A. S., Shine, J., Iismaa, T. P., Scott, M. K., Schmidt, R., & Wynick, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00416.2003 · Cited by 149 · see citing works

Benzodiazepines on trial: a research strategy for their rehabilitation

Costa, E., & Guidetti, A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10015-8 · Cited by 143 · see citing works

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males

Sargentini‐Maier, M. L., Rolan, P. E., Connell, J., Tytgat, D., Jacobs, T. G., Pigeolet, E., Riethuisen, J., & Stockis, A. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02829.x · Cited by 140 · see citing works

Chemical properties of antiepileptic drugs (AEDs)

Bialer, M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.006 · Cited by 139 · see citing works

Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial

Kerrigan, J., Shields, W. D., Nelson, T. Y., Bluestone, D. L., Dodson, W. E., Bourgeois, B. F. D., Pellock, J. M., Morton, L. D., & Monaghan, E. P. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00170-4 · Cited by 138 · see citing works

Valproic Acid: Second Generation

Bialer, M., & Yagen, B. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.007 · Cited by 137 · see citing works

Chronic ingestion of 2-deoxy-d-glucose induces cardiac vacuolization and increases mortality in rats

Minor, R. K., Smith, D. L., Sossong, A. M., Kaushik, S., Poosala, S., Spangler, E. L., Roth, G. S., Lane, M. A., Allison, D. B., de Cabo, R., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.11.025 · Cited by 133 · see citing works

Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man

Matagne, A., & Klitgaard, H. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00016-3 · Cited by 129 · see citing works

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

Rolan, P. E., Sargentini‐Maier, M. L., Pigeolet, E., & Stockis, A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03158.x · Cited by 123 · see citing works

Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure‐induced neurogenesis in the dentate gyrus

Mazarati, A. M., Lü, X., Kilk, K., Langel, Ü., Wasterlain, C. G., & Bartfai, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03449.x · Cited by 120 · see citing works

Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects

Sargentini‐Maier, M. L., Espié, P., Coquette, A., & Stockis, A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017129 · Cited by 118 · see citing works

Fructose-1,6-Bisphosphate Has Anticonvulsant Activity in Models of Acute Seizures in Adult Rats

Lian, X., Khan, F. A., & Stringer, J. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3163-07.2007 · Cited by 115 · see citing works

Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage

Elliott‐Hunt, C. R., Pope, R. J. P., Vanderplank, P. A., & Wynick, D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04239.x · Cited by 113 · see citing works

A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus

Ceolin, L., Bortolotto, Z. A., Bannister, N. J., Collingridge, G. L., Lodge, D., & Volianskis, A. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.035 · Cited by 108 · see citing works

Clinical Evaluation of Ganaxolone in Pediatric and Adolescent Patients with Refractory Epilepsy

Pieribone, V. A., Tsai, J., Soufflet, C., Rey, E., Shaw, K., Giller, E. L., & Dulac, O. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01182.x · Cited by 107 · see citing works

Tolerability and safety of perampanel: two randomized dose-escalation studies

Krauss, G. L., Bar, M., Biton, V., Klapper, J. A., Rektor, I., Vaičienė-Magistris, N., Squillacote, D., & Kumar, D. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01588.x · Cited by 106 · see citing works

Assessment of Ganaxolone's Anticonvulsant Activity Using a Randomized, Double‐Blind, Presurgical Trial Design

Laxer, K. D., Blum, D. E., Abou‐Khalil, B. W., Morrell, M. J., Lee, D. A., Data, J. L., Monaghan, E. P., & the Ganaxolone Presurgical Study Group (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00324.x · Cited by 106 · see citing works

Regulation of Kindling Epileptogenesis by Hippocampal Galanin Type 1 and Type 2 Receptors: The Effects of Subtype-Selective Agonists and the Role of G-Protein-Mediated Signaling

Mazarati, A. M., Lundström, L., Sollenberg, U. E., Shin, D. H., Langel, Ü., & Sankar, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104703 · Cited by 102 · see citing works

Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model

Reddy, D. S., & Rogawski, M. A. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.01.009 · Cited by 100 · see citing works

Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice

Mazarati, A. M., Lü, X., Shinmei, S., Badie-Mahdavi, H., & Bartfai, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.052 · Cited by 99 · see citing works

Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation

Garrett, F. G., & Durham, P. L. (2008) · Neuron Glia Biology · doi:10.1017/s1740925x09990093 · Cited by 88 · see citing works

Seizures in dogs.

Podell, M. (1996) · PubMed · Cited by 85 · see citing works

Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats

Mazarati, A. M., Halászi, E., & Telegdy, G. (1992) · Brain Research · doi:10.1016/0006-8993(92)91179-i · Cited by 84 · see citing works

The galanin peptide family in inflammation

Lang, R., & Kofler, B. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.10.005 · Cited by 78 · see citing works

A Pharmacology Primer

(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-370599-0.x5000-x · Cited by 76 · see citing works

Seizures in Dogs

Podell, M. (1996) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(96)50105-1 · Cited by 76 · see citing works

Tonabersat Inhibits Trigeminal Ganglion Neuronal‐Satellite Glial Cell Signaling

Damodaram, S., Thalakoti, S., Freeman, S. E., Garrett, F. G., & Durham, P. L. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01262.x · Cited by 70 · see citing works

Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture

Zona, C., Pieri, M., Carunchio, I., Curcio, L., Klitgaard, H., & Margineanu, D. G. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.09.024 · Cited by 70 · see citing works

A new derivative of valproic acid amide possesses a broad‐spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage

White, H. S., Alex, A. B., Pollock, A., Hen, N., Shekh‐Ahmad, T., Wilcox, K. S., McDonough, J. H., Stables, J. P., Kaufmann, D., Yagen, B., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03338.x · Cited by 67 · see citing works

Anticonvulsant and proconvulsant actions of 2‐deoxy‐ d ‐glucose

Ga̧sior, M., Yankura, J., Hartman, A. L., French, A., & Rogawski, M. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02593.x · Cited by 63 · see citing works

Design, Synthesis, and Characterization of High-Affinity, Systemically-Active Galanin Analogues with Potent Anticonvulsant Activities

Bulaj, G. W., Green, B. R., Lee, H.-K., Robertson, C. R., White, K. L., Zhang, L., Sochanska, M., Flynn, S. P., Scholl, E. A., Pruess, T. H., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801088x · Cited by 62 · see citing works

Brivaracetam Disposition in Renal Impairment

Sargentini‐Maier, M. L., Sokalski, A., Boulanger, P., Jacobs, T. G., & Stockis, A. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011431457 · Cited by 61 · see citing works

Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors

Mazarati, A. M., & Lü, X. (2005) · Neuropeptides · doi:10.1016/j.npep.2004.12.003 · Cited by 60 · see citing works

Anticonvulsant Efficacy of the Low‐affinity Partial Benzodiazepine Receptor Agonist ELB 138 in a Dog Seizure Model and in Epileptic Dogs with Spontaneously Recurrent Seizures

Löscher, W., Potschka, H., Rieck, S., Tipold, A., & Rundfeldt, C. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.21204.x · Cited by 57 · see citing works

Contemporary Neurology Series

Swanson, P. D. (1970) · Neurology · doi:10.1212/wnl.20.1.102 · Cited by 54 · see citing works

Evaluation of epileptic dogs as an animal model of human epilepsy.

Löscher, W., Schwartz-Porsche, D., Frey, H. ‐., & Schmidt, D. (1985) · PubMed · Cited by 53 · see citing works

Developing Novel Antiepileptic Drugs: Characterization of NAX 5055, a Systemically-Active Galanin Analog, in Epilepsy Models

White, H. S., Scholl, E. A., Klein, B. D., Flynn, S. P., Pruess, T. H., Green, B. R., Zhang, L., & Bulaj, G. W. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.01.001 · Cited by 52 · see citing works

Pharmacokinetics of anti‐epileptic drugs in the dog: a review

Frey, H. ‐., & Löscher, W. (1985) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.1985.tb00951.x · Cited by 52 · see citing works

Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double‐blind, controlled, add‐on clinical trial

Bersudsky, Y., Applebaum, J., Gaiduk, Y., Sharony, L., Mishory, A., Podberezsky, A., Agam, G., & Belmaker, R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00828.x · Cited by 47 · see citing works

Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.

Löscher, W., Hönack, D., Scherkl, R., Hashem, A., & Frey, H. ‐. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22926-3 · Cited by 43 · see citing works

Synthesis and Evaluation of Antiallodynic and Anticonvulsant Activity of Novel Amide and Urea Derivatives of Valproic Acid Analogues

Kaufmann, D., Bialer, M., Shimshoni, J. A., Devor, M. G., & Yagen, B. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901229s · Cited by 41 · see citing works

Behavioral, cognitive, and safety profile of 2-deoxy-2-glucose (2DG) in adult rats.

Ockuly, J., Gielissen, J. M., Levenick, C. V., Zeal, C., Groble, K., Munsey, K., Sutula, T., & Stafstrom, C. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.04.012 · Cited by 37 · see citing works

GABAergic transmission in temporal lobe epilepsy: The role of neurosteroids

Joshi, S., Rajasekaran, K., & Kapur, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.028 · Cited by 36 · see citing works

Engineering Galanin Analogues That Discriminate between GalR1 and GalR2 Receptor Subtypes and Exhibit Anticonvulsant Activity following Systemic Delivery

Robertson, C. R., Scholl, E. A., Pruess, T. H., Green, B. R., White, H. S., & Bulaj, G. W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9018349 · Cited by 36 · see citing works

Structural Requirements for a Lipoamino Acid in Modulating the Anticonvulsant Activities of Systemically Active Galanin Analogues

Zhang, L., Robertson, C. R., Green, B. R., Pruess, T. H., White, H. S., & Bulaj, G. W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801397w · Cited by 36 · see citing works

Effect of brivaracetam on cardiac repolarisation – a thorough QT study

Rosillon, D., Astruc, B., Hulhoven, R., Meeus, M.-A., Troenaru, M., Watanabe, S., & Stockis, A. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802278453 · Cited by 35 · see citing works

The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteers

Elman, I., Sokoloff, L., Adler, C. M., Weisenfeld, N., & Breier, A. F. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01137-8 · Cited by 30 · see citing works

Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid

Kaufmann, D., Yagen, B., Minert, A., Wlodarczyk, B. J., Finnell, R. H., Schurig, V., Devor, M. G., & Bialer, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.03.004 · Cited by 27 · see citing works

Brivaracetam does not alter spatial learning and memory in both normal and amygdala-kindled rats

Detrait, E., Leclercq, K., Löscher, W., Potschka, H., Niespodziany, I., Hanon, É., Kaminski, R. M., Matagne, A., & Lamberty, Y. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.06.014 · Cited by 23 · see citing works

Comparative studies of the influence of various K+ concentrations on the action of K-strophanthidin, digitoxin and strophanthidin-3-bromoacetate on papillary muscle and on membrane-atpase of guinea pig hearts

Fricke, U., & Klaus, W. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90070-7 · Cited by 22 · see citing works

The antiepileptic drug AWD 131–138 stimulates different recombinant isoforms of the GABAA receptor through the benzodiazepine binding site

Sigel, E., Baur, R., Netzer, R., & Rundfeldt, C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00186-4 · Cited by 22 · see citing works

AWD-131-138

Rostock, A., Tober, C., Dost, R., Rundfeldt, C., Bartsch, R., Egerland, U., Stark, B., Schupke, H., Kronbach, T., Lankau, H., et al. (1998) · Drugs of the Future · doi:10.1358/dof.1998.023.03.450427 · Cited by 20 · see citing works

Physiologically Based Pharmacokinetic/Pharmacodynamic Animal‐to‐Man Prediction of Therapeutic Dose in a Model of Epilepsy

Brochot, A., Zamacona, M. K., & Stockis, A. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00536.x · Cited by 19 · see citing works

Responses to the combination of the glycolytic inhibitor 2-deoxy-glucose (2DG) and docetaxel (DC) in patients with lung and head and neck (H/N) carcinomas

Raez, L. E., Langmuir, V. K., Tolba, K., Rocha‐Lima, C., Papadopoulos, K., Kroll, S., Brawer, M. K., Rosenblatt, J. D., Ricart, A. D., & Lampidis, T. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.14025 · Cited by 16 · see citing works

Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys

Yaşar, S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01533-4 · Cited by 10 · see citing works

Pharmacokinetics of Brivaracetam in Subjects With Hepatic Impairment and in Matched Healthy Controls

Horsmans, Y., Sargentini‐Maier, M. L., & Stockis, A. (2009) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · Cited by 8 · see citing works

LOCAL DELIVERY OF ADENOSINE HAS AN ANTIEPILEPTIC EFFECT IN RATS WITH SPONTANEOUS SEIZURES

Dycke, A. V., Raedt, R., Dauwe, I., Wyckhuys, T., Herdt, V. D., Tahry, R. E., Meurs, A., Vonck, K. E. J., Wadman, W. J., & Boon, P. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 8 · see citing works

Pharmacokinetics of Brivaracetam in Subjects With Hepatic Impairment and in Matched Healthy Controls

Stockis, A., Horsmans, Y., Sargentini-Maier, M. L., Boulton, M., & 62nd Annual Meeting of the American-Epilepsy-Society (2008) · Digital Access to Libraries · Cited by 2 · see citing works

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 928 · see citing works

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 907 · see citing works

New avenues for anti-epileptic drug discovery and development

Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675 · see citing works

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial

Krauss, G. L., Klein, P., Brandt, C., Lee, S. K., Milanov, I. G., Milovanović, M., Steinhoff, B. J., & Kamin, M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30399-0 · Cited by 347 · see citing works

Pathogenesis of acute stroke and the role of inflammasomes

Fann, D. Y., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 334 · see citing works

The role of inflammasomes in kidney disease

Komada, T., & Muruve, D. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0158-z · Cited by 311 · see citing works

Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation

Kaushal, V, Dye, R., Pakavathkumar, P., Foveau, B., Flores, J., Hyman, B., Ghetti, B., Koller, B. H., & LeBlanc, A. C. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.16 · Cited by 297 · see citing works

Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model

Flores, J., Noël, A., Foveau, B., Lynham, J., Lecrux, C., & LeBlanc, A. C. (2018) · Nature Communications · doi:10.1038/s41467-018-06449-x · Cited by 288 · see citing works

Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies

van Vliet, E. A., Aronica, E., Vezzani, A., & Ravizza, T. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12444 · Cited by 260 · see citing works

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures

Chung, S. S., French, J. A., Kowalski, J., Krauss, G. L., Lee, S. K., Maciejowski, M., Rosenfeld, W. E., Sperling, M. R., Mizne, S., & Kamin, M. (2020) · Neurology · doi:10.1212/wnl.0000000000009530 · Cited by 248 · see citing works

Therapeutic modulation of inflammasome pathways

Chauhan, D., Walle, L. V., & Lamkanfi, M. (2020) · Immunological Reviews · doi:10.1111/imr.12908 · Cited by 217 · see citing works

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

Sperling, M. R., Klein, P., Aboumatar, S., Gelfand, M. A., Halford, J. J., Krauss, G. L., Rosenfeld, W. E., Vossler, D. G., Wechsler, R. T., Borchert, L. D., et al. (2020) · Epilepsia · doi:10.1111/epi.16525 · Cited by 218 · see citing works

Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside

Dey, A., Xu, K., Qiu, J., Du, Y., & Jiang, J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.001 · Cited by 216 · see citing works

A long way to go: caspase inhibitors in clinical use

Dhani, S., Zhao, Y., & Zhivotovsky, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04240-3 · Cited by 200 · see citing works

Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy

Iori, V., Iyer, A. M., Ravizza, T., Beltrame, L., Paracchini, L., Marchini, S., Cerovic, M., Hill, C., Ferrari, M., Zucchetti, M., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.007 · Cited by 177 · see citing works

Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs

Patsalos, P. N. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0087-0 · Cited by 185 · see citing works

Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.01.001 · Cited by 174 · see citing works

Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons

Nakamura, M., Cho, J., Shin, H., & Jang, I. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.007 · Cited by 166 · see citing works

Inflammasome components as new therapeutic targets in inflammatory disease

Coll, R. C., & Schroder, K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01075-9 · Cited by 168 · see citing works

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

Paugh, S. W., Bonten, E. J., Savic, D., Ramsey, L. B., Thierfelder, W. E., Gurung, P., Malireddi, R. K. S., Actis, M., Mayasundari, A., Min, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3283 · Cited by 164 · see citing works

Neuroactive steroids for the treatment of status epilepticus

Rogawski, M. A., Loya, C. M., Reddy, K., Żółkowska, D., & Lossin, C. (2013) · Epilepsia · doi:10.1111/epi.12289 · Cited by 155 · see citing works

Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies

Guery, D., & Rheims, S. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s256699 · Cited by 150 · see citing works

Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development

Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16725 · Cited by 149 · see citing works

Astrocytes as Guardians of Neuronal Excitability: Mechanisms Underlying Epileptogenesis

Verhoog, Q. P., Holtman, L., Aronica, E., & van Vliet, E. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.591690 · Cited by 144 · see citing works

The Interconnected Mechanisms of Oxidative Stress and Neuroinflammation in Epilepsy

Parsons, A. L. M., Bucknor, E. M. V., Castroflorio, E., Soares, T. R., Oliver, P. L., & Rial, D. (2022) · Antioxidants · doi:10.3390/antiox11010157 · Cited by 147 · see citing works

Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate

Sharma, R., Nakamura, M., Neupane, C., Jeon, B. H., Shin, H., Melnick, S. M., Glenn, K., Jang, I., & Park, J. B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173117 · Cited by 135 · see citing works

Pediatric super‐refractory status epilepticus treated with allopregnanolone

Broomall, E. M., Natale, J. E., Grimason, M., Goldstein, J. L., Smith, C. M., Chang, C. H., Kanes, S., Rogawski, M. A., & Wainwright, M. S. (2014) · Annals of Neurology · doi:10.1002/ana.24295 · Cited by 120 · see citing works

Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices ( EILAT XIII )

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2017) · Epilepsia · doi:10.1111/epi.13634 · Cited by 110 · see citing works

Neuroinflammation microenvironment sharpens seizure circuit.

Villasana-Salazar, B., & Vezzani, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106027 · Cited by 99 · see citing works

Amino Acids in the Development of Prodrugs

Vale, N., Ferreira, A., Matos, J., Fresco, P., & Gouveia, M. J. (2018) · Molecules · doi:10.3390/molecules23092318 · Cited by 107 · see citing works

microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus

Jimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 94 · see citing works

Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets

Sharma, R., Leung, W. L., Zamani, A., O'Brien, T. J., Casillas-Espinosa, P. M., & Semple, B. D. (2019) · Brain Sciences · doi:10.3390/brainsci9110318 · Cited by 102 · see citing works

Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies

Ravizza, T., & Vezzani, A. (2018) · Epilepsia Open · doi:10.1002/epi4.12242 · Cited by 96 · see citing works

ATPergic signalling during seizures and epilepsy

Engel, T., Alves, M., Sheedy, C., & Henshall, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.001 · Cited by 95 · see citing works

Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder

Pinna, G., & Rasmusson, A. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00256 · Cited by 94 · see citing works

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs

Štrac, D. Š., Pivac, N., Smolders, I. J., Fogel, W. A., Deurwaerdère, P. D., & Giovanni, G. D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00492 · Cited by 93 · see citing works

The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments

Kaminski, R. M., Rogawski, M. A., & Klitgaard, H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0266-1 · Cited by 89 · see citing works

Neural progenitor cell pyroptosis contributes to Zika virus-induced brain atrophy and represents a therapeutic target

He, Z., An, S., Chen, J., Zhang, S., Tan, C., Yu, J., Ye, H., Wu, Y., Yuan, J. X., Wu, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007773117 · Cited by 88 · see citing works

Development and pharmacologic characterization of the rat 6 Hz model of partial seizures

Metcalf, C. S., West, P. J., Thomson, K. E., Edwards, S. F., Smith, M. D., White, H. S., & Wilcox, K. S. (2017) · Epilepsia · doi:10.1111/epi.13764 · Cited by 84 · see citing works

Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?

Guignet, M. A., Campbell, A., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16718 · Cited by 83 · see citing works

Altered expression of δGABAA receptors in health and disease

Whissell, P. D., Lecker, I., Wang, D.-S., Yu, J., & Orser, B. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.003 · Cited by 81 · see citing works

Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics

Islamuddin, M., & Qin, X.-B. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01996-3 · Cited by 81 · see citing works

Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels

Kim, Y., Griffin, J. M., Nor, M. N. M., Zhang, J., Freestone, P. S., Danesh-Meyer, H. V., Rupenthal, I. D., Acosta, M. L., Nicholson, L. F. B., O’Carroll, S. J., et al. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0536-9 · Cited by 81 · see citing works

Caspase-1 inhibition mediates neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-κB activation

Li, Q., Dai, Z., Cao, Y., & Wang, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.202 · Cited by 78 · see citing works

Modelling epilepsy in the mouse: challenges and solutions

Marshall, G. F., Gonzalez‐Sulser, A., & Abbott, C. M. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047449 · Cited by 73 · see citing works

The role of inflammation in epileptogenesis

Meng, F., & Yao, L. (2020) · Acta Epileptologica · doi:10.1186/s42494-020-00024-y · Cited by 73 · see citing works

The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?

Löscher, W., Sills, G. J., & White, H. S. (2021) · Epilepsia · doi:10.1111/epi.16832 · Cited by 71 · see citing works

Advances in anti-epileptic drug testing

Krasowski, M. D., & McMillin, G. A. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.002 · Cited by 71 · see citing works

Antiepileptogenesis in humans

Trinka, E., & Brigo, F. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000067 · Cited by 70 · see citing works

Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis

Lattanzi, S., Trinka, E., Zaccara, G., Striano, P., Giovane, C. D., Silvestrini, M., & Brigo, F. (2020) · CNS Drugs · doi:10.1007/s40263-020-00759-9 · Cited by 69 · see citing works

Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging

van Vliet, E. A., & Marchi, N. (2022) · Epilepsia · doi:10.1111/epi.17210 · Cited by 68 · see citing works

Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS

Almad, A. A., Taga, A., Joseph, J., Gross, S. K., Welsh, C., Patankar, A. G., Richard, J., Rust, K., Pokharel, A., Plott, C. F., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107391119 · Cited by 68 · see citing works

A resurging boom in new drugs for epilepsy and brain disorders

Younus, I., & Reddy, D. S. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1386553 · Cited by 64 · see citing works

Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy

Barker‐Haliski, M. L., Johnson, K. J., Billingsley, P., Huff, J. L., Handy, L. J., Khaleel, R., Lu, Z., Mau, M. J., Pruess, T. H., Rueda, C. B., et al. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2227-7 · Cited by 63 · see citing works

Brain activity patterns in high-throughput electrophysiology screen predict both drug efficacies and side effects

Eimon, P. M., Ghannad‐Rezaie, M., Rienzo, G. D., Allalou, A., Wu, Y., Gao, M., Roy, A., Skolnick, J., & Yanik, M. F. (2018) · Nature Communications · doi:10.1038/s41467-017-02404-4 · Cited by 65 · see citing works

Zebrafish Bioassay-Guided Microfractionation Identifies Anticonvulsant Steroid Glycosides from the Philippine Medicinal PlantSolanum torvum

Challal, S., Buenafe, O. E. M., Queiroz, E. F., Maljevic, S., Marcourt, L., Bock, M., Kloeti, W., Dayrit, F. M., Harvey, A. L., Lerche, H., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5001342 · Cited by 62 · see citing works

Phosphorylation of GABAA receptors influences receptor trafficking and neurosteroid actions

Comenencia-Ortiz, E., Moss, S. J., & Davies, P. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3617-z · Cited by 62 · see citing works

Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment‐resistant status epilepticus

Żółkowska, D., Wu, C., & Rogawski, M. A. (2018) · Epilepsia · doi:10.1111/epi.13999 · Cited by 61 · see citing works

Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy

Schipper, S., Aalbers, M. W., Rijkers, K., Swijsen, A., Rigo, J., Hoogland, G., & Vles, J. S. H. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9423-8 · Cited by 58 · see citing works

Action of antiepileptic drugs on neurons

Kobayashi, K., Endoh, F., Ohmori, I., & Akiyama, T. (2019) · Brain and Development · doi:10.1016/j.braindev.2019.07.006 · Cited by 56 · see citing works

Involvement of gap junction channels in the pathophysiology of migraine with aura

Sarrouilhe, D., Dejean, C., & Mesnil, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00078 · Cited by 56 · see citing works

Brivaracetam Single and Multiple Rising Oral Dose Study in Healthy Japanese Participants: Influence of CYP2C19 Genotype

Stockis, A., Watanabe, S., Rouits, E., Matsuguma, K., & Irie, S. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-14-rg-010 · Cited by 56 · see citing works

Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair

Israelov, H., Ravid, O., Atrakchi, D., Rand, D., Goldman, S. E., Bresler, Y., Twitto‐Greenberg, R., Omesi, L., Zaltsman, S. L., Gosselet, F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01927-w · Cited by 53 · see citing works

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile

Mishra, M., Kukal, S., Paul, P. R., Bora, S., Singh, A., Kukreti, S., Saso, L., Muthusamy, K., Hasija, Y., & Kukreti, R. (2021) · Molecules · doi:10.3390/molecules27010104 · Cited by 53 · see citing works

Research Progress on the Role of Inflammasomes in Kidney Disease

Chi, K., Geng, X., Liu, C., Cai, G., & Hong, Q. (2020) · Mediators of Inflammation · doi:10.1155/2020/8032797 · Cited by 53 · see citing works

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis

Jiang, Q., Wang, X., Huang, E., Wang, Q., Wen, C., Yang, G., Lu, L., & Cui, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816839 · Cited by 55 · see citing works

Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development

Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16726 · Cited by 52 · see citing works

Pyroptosis and Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Implications

Ge, Y., Chen, Y., Guo, C., Luo, H., Fu, F., Ji, W., Wu, C., & Ruan, H. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s382069 · Cited by 52 · see citing works

Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)

Trenité, D. G. A. K.-N., DiVentura, B. D., Pollard, J. R., Krauss, G. L., Mizne, S., & French, J. A. (2019) · Neurology · doi:10.1212/wnl.0000000000007894 · Cited by 52 · see citing works

Successful treatment of adult Dravet syndrome patients with cenobamate

Makridis, K. L., Friedo, A., Kellinghaus, C., Losch, F., Schmitz, B., Boßelmann, C. M., & Kaindl, A. M. (2022) · Epilepsia · doi:10.1111/epi.17427 · Cited by 51 · see citing works

Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes

Flammer, J., Neziraj, T., Rüegg, S. J., & Pröbstel, A. (2023) · Drugs · doi:10.1007/s40265-022-01826-9 · Cited by 51 · see citing works

In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy

Campos, G., Fortuna, A. C., Falcão, A. C., & Alves, G. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.07.008 · Cited by 51 · see citing works

Early add‐on treatmentvsalternative monotherapy in patients with partial epilepsy

Semah, F., Thomas, P., Coulbaut, S., & Derambure, P. (2014) · Epileptic Disorders · doi:10.1684/epd.2014.0650 · Cited by 50 · see citing works

The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart

Popov, S. V., Маслов, Л. Н., Naryzhnaya, N. V., Mukhomedzyanov, А. V., Krylatov, A. V., Tsibulnikov, S. Y., Ryabov, V. V., Cohen, M. V., & Downey, J. M. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484211027405 · Cited by 48 · see citing works

Targeting gap junction in epilepsy: Perspectives and challenges

Qin, L., Li, Q.-Q., Jia, J.-N., Liu, Z., Zhou, H., & Mao, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.068 · Cited by 49 · see citing works

The anticonvulsant retigabine is a subtype selective modulator of GABA A receptors

Treven, M., Koenig, X., Assadpour, E., Gantumur, E., Meyer, C., Hilber, K., Boehm, S., & Kubista, H. (2015) · Epilepsia · doi:10.1111/epi.12950 · Cited by 48 · see citing works

Ganaxolone: A New Treatment for Neonatal Seizures

Yawno, T., Miller, S. L., Bennet, L., Wong, F. Y., Hirst, J. J., Fahey, M. C., & Walker, D. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00246 · Cited by 48 · see citing works

Cenobamate treatment of focal-onset seizures: Quality of life and outcome during up to eight years of treatment

Elizebath, R., Zhang, E. X., Coe, P., Gutierrez, E. G., Yang, J., & Krauss, G. L. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107796 · Cited by 47 · see citing works

Structure‐based discovery of CZL80, a caspase‐1 inhibitor with therapeutic potential for febrile seizures and later enhanced epileptogenic susceptibility

Tang, Y., Feng, B., Wang, Y., Sun, H., You, Y., Yu, J., Chen, B., Xu, C., Ruan, Y., Cui, S., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15076 · Cited by 46 · see citing works

Systems biology, complexity, and the impact on antiepileptic drug discovery

Margineanu, D. G. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.029 · Cited by 43 · see citing works

Disease Modification in Epilepsy: From Animal Models to Clinical Applications

Barker‐Haliski, M. L., Friedman, D., French, J. A., & White, H. S. (2015) · Drugs · doi:10.1007/s40265-015-0395-9 · Cited by 45 · see citing works

The Riluzole Derivative 2-Amino-6-trifluoromethylthio-benzothiazole (SKA-19), a Mixed KCa2 Activator and NaV Blocker, is a Potent Novel Anticonvulsant

Coleman, N., Nguyen, H. M., Cao, Z., Brown, B. M., Jenkins, D. P., Żółkowska, D., Chen, Y., Tanaka, B. S., Goldin, A. L., Rogawski, M. A., et al. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0305-y · Cited by 42 · see citing works

Targeting Kv7 Potassium Channels for Epilepsy

Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43 · see citing works

Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model

Ciarlone, S. L., Wang, X., Rogawski, M. A., & Weeber, E. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.009 · Cited by 41 · see citing works

The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy

Alves, M., Beamer, E. H., & Engel, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00193 · Cited by 41 · see citing works

Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation

D’Ambrosio, R., Eastman, C. L., Fattore, C., & Perucca, E. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.54 · Cited by 40 · see citing works

The Role of Neuroinflammation in Post-traumatic Epilepsy

Sun, L., Wei, S., Yang, H.-J., Liu, R., Wu, J.-P., & Wang, Q. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.646152 · Cited by 35 · see citing works

The NLRP1 Inflammasome Induces Pyroptosis in Human Corneal Epithelial Cells

Griswold, A. R., Huang, H., & Bachovchin, D. A. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.3.2 · Cited by 40 · see citing works

Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin D1

Musto, A. E., Walker, C. P., Petasis, N. A., & Bazan, N. G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116543 · Cited by 39 · see citing works

Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment

Bruna, J., Miró, J., & Velasco, R. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.12 · Cited by 38 · see citing works

The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models

Palumbo, L., Carinci, M., Guarino, A., Asth, L., Zucchini, S., Missiroli, S., Rimessi, A., Pinton, P., & Giorgi, C. (2023) · Biomedicines · doi:10.3390/biomedicines11102825 · Cited by 38 · see citing works

Systemic inflammation exacerbates developmental neurotoxicity induced by sevoflurane in neonatal rats

Useinovic, N., Maksimovic, S., Liechty, C., Cabrera, O. H., Quillinan, N., & Jevtović‐Todorović, V. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.05.008 · Cited by 36 · see citing works

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations

Schmitz, B., Lattanzi, S., Vonck, K. E. J., Kälviäinen, R. K., Nashef, L. A. M., & Ben‐Menachem, E. (2023) · Epilepsia Open · doi:10.1002/epi4.12830 · Cited by 35 · see citing works

VX‐765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke‐induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway

Sun, Z., Gu, L., Wu, K., Wang, K., Ru, J., Yang, S., Wang, Z., Zhuge, Q., Huang, L., & Huang, S. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13400 · Cited by 34 · see citing works

Rapid Throughput Analysis Demonstrates that Chemicals with Distinct Seizurogenic Mechanisms Differentially Alter Ca2+ Dynamics in Networks Formed by Hippocampal Neurons in Culture

Cao, Z., Zou, X., Cui, Y., Hulsizer, S., Lein, P. J., Wulff, H., & Pessah, I. N. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096701 · Cited by 34 · see citing works

Drug treatment in patients with newly diagnosed unprovoked seizures/epilepsy

Karlsson, L., Wettermark, B., & Tomson, T. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.03.004 · Cited by 33 · see citing works

Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development

Zaccara, G., & Schmidt, D. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.011 · Cited by 33 · see citing works

Recent progress of 1,3,4‐oxadiazoles as anticonvulsants: Future horizons

Nazar, S., Siddiqui, N., & Alam, O. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.201900342 · Cited by 33 · see citing works

Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase

Kudin, A. P., Mawasi, H., Eisenkraft, A., Elger, C. E., Bialer, M., & Kunz, W. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091912 · Cited by 33 · see citing works

Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women

Stockis, A., & Rolan, P. E. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.187 · Cited by 32 · see citing works

Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.09.001 · Cited by 179 · see citing works

Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.09.005 · Cited by 225 · see citing works

Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.01.001 · Cited by 174 · see citing works

Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)

Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477 · see citing works

Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices ( EILAT XIII )

Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2017) · Epilepsia · doi:10.1111/epi.13634 · Cited by 110 · see citing works